Department of Neurology, First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China.
J Mol Neurosci. 2014 Jun;53(2):280-6. doi: 10.1007/s12031-013-0218-y. Epub 2014 Jan 4.
Methylmalonic acidemia (MMA) is a metabolic disorder, which is caused by a deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase. MMA diagnosis is dependent on the method of gas chromatography-mass spectrometry, which is expensive, complicated, and time consuming. Currently, microRNAs (miRNAs) have gained considerable interest for its function as a novel class of non-invasive and sensitive biomarkers for the diagnosis of diseases. However, there has been no related report regarding its role in MMA. Our study first detected differentially expressed microRNAs in MMA and found that the expression of miR-9-1 was significantly down-regulated and changed sensitively after VitB12 treatment. Furthermore, we confirmed that miR-9-1 was able to suppress neuronal apoptosis induced by methylmalonate. Taken together, our results suggested that miR-9-1 may act as a potential biomarker for the diagnosis and monitoring of changes in MMA and provide new insights into the pathogenesis of MMA.
甲基丙二酸血症(MMA)是一种代谢紊乱,由线粒体酶甲基丙二酰辅酶 A 变位酶缺乏引起。MMA 的诊断依赖于气相色谱-质谱联用的方法,该方法昂贵、复杂且耗时。目前,microRNAs(miRNAs)作为一种新型的非侵入性和敏感的疾病诊断生物标志物,引起了相当大的关注。然而,关于其在 MMA 中的作用尚无相关报道。我们的研究首次检测到 MMA 中差异表达的 microRNAs,发现 miR-9-1 的表达明显下调,并且在 VitB12 治疗后变化敏感。此外,我们证实 miR-9-1 能够抑制甲基丙二酸诱导的神经元凋亡。总之,我们的研究结果表明,miR-9-1 可能作为 MMA 诊断和监测变化的潜在生物标志物,并为 MMA 的发病机制提供新的见解。